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Abstract: Short-term persistence of transplanted cells during early post-implant period limits clinical
efficacy of cell therapy. Poor cell survival is mainly due to the harsh hypoxic microenvironment
transplanted cells face at the site of implantation and to anoikis, driven by cell adhesion loss. We
evaluated the hypothesis that viral-mediated expression of a gene conferring hypoxia resistance to
cells before transplant could enhance survival of grafted cells in early stages after implant. We used
adipose tissue as cell source because it consistently provides high yields of adipose-tissue-derived
stromal and vascular cells (ASCs), suitable for regenerative purposes. Luciferase positive cells
were transduced with lentiviral vectors expressing either green fluorescent protein as control or
human manganese superoxide dismutase (SOD2). Cells were then exposed in vitro to hypoxic
conditions, mimicking cell transplantation into an ischemic site. Cells overexpressing SOD2 displayed
survival rates significantly greater compared to mock transduced cells. Similar results were also
obtained in vivo after implantation into syngeneic mice and assessment of cell engraftment by in vivo
bioluminescent imaging. Taken together, these findings suggest that ex vivo gene transfer of SOD2
into ASCs before implantation confers a cytoprotective effect leading to improved survival and
engraftment rates, therefore enhancing cell therapy regenerative potential.
Keywords: adipose tissue-derived stromal and vascular cells; bioluminescence imaging; cell therapy;
cell survival; cell transplantation; hypoxia; manganese superoxide dismutase; oxidative stress;
reactive oxygen species
1. Introduction
Cell therapy is an innovative approach for the treatment of some acute and chronic degenerative
conditions [1]. Transplanted cells may promote tissue regeneration through different mechanisms,
including cell differentiation, cell fusion and paracrine effects via the secretion of various cytokines,
growth factors and/or microvesicles. At any rate, the therapeutic effect of cell-based therapies
ultimately depends on the persistence of cells at the site of tissue injury. Poor transplanted cell survival
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soon after in vivo transfer is slowing research progress and clinical translation of cell therapy [2]. One
of the major reasons for early implanted cell death is the lack of oxygenation resulting for delayed
revascularization at the transplantation site. Oxygen diffusion only sustains cells to a distance of
approximately 200 micron from the oxygen source [3]. Thus, direct injection into damaged tissue
exposes transplanted cells to prolonged periods of hypoxia. In addition, cell transplantation procedures
involve cell detachment from the extracellular matrix; disruption of cell-matrix contact also promotes
a strong increase of reactive oxygen species (ROS) production, triggering anoikis [4]. Therefore, the
benefits of cell transplantation could be improved by adapting donor cells in order to enhance their
resistance to hypoxic stress [5–8].
Anti-death strategies have been explored to promote the survival of transplanted cells and increase
the therapeutic potential of transplantation therapy [9–11]. These methods include continuous infusion
of trophic factors and hypoxic preconditioning [12]. Alternatively, survival and regenerative capability
of transplanted cells can be improved in vitro before transplantation [13–16].
Response to oxidative stress and anoikis are very complex and the networks of genes involved
not fully elucidated. Cell exposure to low oxygen leads to an increased generation of oxygen species
by dysfunctional mitochondria [17]. Accordingly, the mitochondrial superoxide scavenger superoxide
dismutase 2 (MnSOD or SOD2) gene is strongly upregulated during hypoxic preconditioning,
underlining its pivotal role in hypoxic stress resistance by ROS detoxification [18]. In fact, SOD2 helps
in preventing peroxynitrite formation by conversion of superoxide anion to hydrogen peroxide, which
is then reduced to water. Moreover, SOD2 expression in highly upregulated during cell detachment
from the extracellular matrix in order to confer anoikis resistance [19].
Adipose tissue represents an attractive source for isolating stromal and vascular cells suitable for
cell therapies aimed at tissue regeneration [20–22]. Adipose tissue-derived stromal cells (ASCs) [23]
are collected from adipose tissue by collagenase digestion and differential centrifugation. ASCs
are able to differentiate into several cells types of both mesodermal and nonmesodermal origin,
including adipocytes, chondrocytes, osteocytes, myocytes, hepatocytes, endocrine pancreatic cells,
and neurons [21]. In particular, ASCs are suitable for vascular regeneration, since they are able to
differentiate into endothelial cells and form vessel-like structures that assume endothelial function in
Matrigel [24–26]. Moreover, ASCs are able to exert an antioxidant effect via a paracrine mechanism [27].
Here we provide evidence that ex vivo genetic modification of ASCs by lentiviral-mediated SOD2
gene transfer provides a benefit by promoting cell survival to hypoxia in vitro and by enhancing
engraftment in vivo.
2. Results
2.1. Lentiviral-Mediated Gene Transfer into Adipose-Tissue-Derived Stromal and Vascular Cells (ASCs)
Adipose tissue-derived stromal and vascular cells were isolated from lipoaspirates obtained
from human donors [24]. A lentiviral vector (LV) for expression of human superoxide dismutase 2
(SOD2) was generated and used for gene transfer into ASCs. Immunoblotting using anti-SOD2
antibodies followed by densitometric analysis revealed a 2.5-fold increased expression upon SOD2
gene transfer, compared to mock-transduced ASCs (Figure 1A,B). In addition, SOD activity was
assayed by non-denaturing polyacrylamide gel electrophoresis followed by specific riboflavin-nitroblue
tetrazolium staining and densitometric analysis (Figure 1C,D). Further determination of SOD activity
after lentiviral-mediated SOD2 gene transfer into ASCs was obtained using a specific determination
kit (Sigma-Aldrich, St. Louis, MO, USA) (Figure 1E). Both methods were in agreement in determining
that enzymatic activity in SOD2 overexpressing cells was approximately 1.5–2.5 folds higher compared
to mock-transduced cells.
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Figure 1. Lentiviral-mediated SOD2 gene transfer into ASCs. (A) Immunoblotting and (B) 
densitometric analysis in mock- and SOD2-transduced ASCs: the blot was probed with a primary 
antibody specific for human SOD2, and one directed against GAPDH as normalization control. 
SOD-activity determined by (C) non-denaturing polyacrylamide gel electrophoresis and 
riboflavin-nitroblue tetrazolium staining followed by (D) densitometric analysis and (E) SOD 
determination kit in mock- and SOD2-transduced ASCs. In each panel, the asterisk (*) indicates a 
significant difference versus the control group, assessed by unpaired Mann–Whitney U test (p < 0.05). 
We aimed at testing whether SOD2 overexpression into ASCs might result into enhanced cell 
engraftment rate in vivo upon transplant into an experimental animal model. A suitable way to 
assess improved engraftment of SOD2-expressing ASC, in comparison with mock transduced ASC, 
is by means of sensitive, noninvasive bioluminescent imaging (BLI) upon firefly luciferase gene 
transfer. To this end, we needed to obtain murine ASCs expressing both firefly luciferase and SOD2. 
We therefore tested the susceptibility of freshly isolated murine ASCs to lentiviral-mediated gene 
transfer in suspension, using a “Suspension with Lentiviral vectors and Immediately Transplanted 
(SLIT)” protocol originally developed for gene transfer into transplantable primary hepatocytes [28]. 
Extensive ex vivo expansion may affect chromosomal stability, differentiation potential and cell 
adhesion characteristic of ASCs, possibly modifying their homing capabilities [29]. The described 
methodology allows for high rates gene transfer through minimal in vitro manipulation, therefore 
reducing the issues associated with prolonged in vitro long-term cell expansion. We used a LV 
expressing enhanced green fluorescent protein (GFP) under the ubiquitous human 
phosphoglycerate kinase (PGK) promoter [30]. Upon lentiviral-mediated gene transfer at 
multiplicity of infection 30, in suspension for two hours we achieve up to 89% transduction, as 
assessed by GFP expression determined by flow cytometric (FACS) and fluorescent microscopy 
analysis performed after 48 h of culture in order to allow for efficient transgene expression. Using 
this procedure, we obtained firefly luciferase (fLuc) expressing ASCs, which were co-transduced 
with LV vectors expressing either GFP as control or SOD2. Luciferase-positive cells expressing either 
GFP or SOD2 had a comparable light emission profile as assessed by BLI imaging indicating that 
co-expression with a second transgene does not affect luciferase expression. 
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We aimed at testing whether SOD2 overexpression into ASCs might result into enhanced cell
engraftment rate in vivo upon transplant into an experimental animal model. A suitable way to
assess improved engraftment of SOD2-expressing ASC, in comparison with mock transduced ASC,
is by means of sensitive, noninvasive bioluminescent imaging (BLI) upon firefly luciferase gene
transfer. To this end, we needed to obtain murine ASCs expressing both firefly luciferase and SOD2.
We therefore tested the susceptibility of freshly isolated murine ASCs to lentiviral-mediated gene
transfer in suspension, using a “Suspension with Lentiviral vectors and Immediately Transplanted
(SLIT)” protocol originally developed for gene transfer into transplantable primary hepatocytes [28].
Extensive ex vivo expansion may affect chromosomal stability, differentiation potential and cell
adhesion characteristic of ASCs, possibly modifying their homing capabilities [29]. The described
methodology allows for high rates gene transfer through minimal in vitro manipulation, therefore
reducing the issues associated with prolonged in vitro long-term cell expansion. We used a LV
expressing enhanced green fluorescent protein (GFP) under the ubiquitous human phosphoglycerate
kinase (PGK) promoter [30]. Upon lentiviral-mediated gene transfer at multiplicity of infection 30,
in suspension for two hours we achieve up to 89% transduction, as assessed by GFP expression
determined by flow cytometric (FACS) and fluorescent microscopy analysis performed after 48 h of
culture in order to allow for efficient transgene expression. Using this procedure, we obtained firefly
luciferase (fLuc) expressing ASCs, which were co-transduced with LV vectors expressing either GFP
as control or SOD2. Luciferase-positive cells expressing either GFP or SOD2 had a comparable light
emission profile as assessed by BLI imaging indicating that co-expression with a second transgene
does not affect luciferase expression.
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2.2. Lentiviral-Mediated Gene Transfer into ASCs of Superoxide Dismutase 2 (SOD2) Confers Improved
Resistance to Hypoxia in Vitro
We evaluated the performance of mock- and SOD2-transduced human ASCs cultured in hypoxic
condition in vitro. Firstly, we assessed the production of ROS following exposure of ASCs to 1 mM
H2O2 for 30 min. SOD2-expressing cell culture displayed reduced ROS production following acute
hypoxic stress, as determined by fluorescence microscopy with the ROS-sensitive CellROX oxidative
stress reagent fluorogenic probe (Figure 2A). Additionally, ASCs were exposed to prolonged hypoxic
conditions achieved by adding increasing concentration of CoCl2 to the culture medium. After 24 h
cell viability was assessed by the WST-1 cell proliferation assay kit, reveling that SOD2 expressing
ASC viability was increased compared to mock ASC (p ď 0.05) and comparable to the levels of ASC
mock cells treated with the antioxidant N-acetylcysteine (NaC) (Figure 2B).
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24 h of culture in cobalt chloride-induced hypoxic conditions (C). Treatment with the antioxidant 
scavenger N-acetylcysteine (NaC) (2 mM) was used as control. Results are reported as mean ± S.E.M. 
of three independent experiments. Significance was assessed by Mann–Whitney U test; * p < 0.05 
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Accordingly, to validate our experimental design before studies involving animals, we wanted 
to test the performance of mock- and SOD2-transduced, luciferase expressing murine ASCs  
cultured in hypoxic condition in vitro. To mimic the hypoxic environment which cell face upon 
transplantation, we cultured luciferase-expressing ASCs in a modular airtight humidified chamber 
flushed with a gas mixture which consisted of 95% N2 and 5% CO2 for three days. Bioluminescent 
imaging (BLI) analysis was performed before hypoxia induction and after three days of culture  
in hypoxic condition (Figure 3). At the 72 h time point, BLI imaging signal detected in 
SOD2-overexpressing cells was statistically significantly higher than the one observed in mock 
transduced cells (Figure 3B). In the current experimental setting, stronger bioluminescence signal 
correlates with improved survival of SOD2-expressing cells, compared to mock (GFP)-transduced 
control. BLI analysis performed on cells undergoing the same gene transfer procedure, but 
maintained in normoxic condition did not reveal any significant difference amongst the groups. 
Figure 2. ROS production in SOD2 overexpressing human ASC after acute hypoxic challenge
(1 mM H2O2 for 30 min) assessed using (A) the CellROX oxidative stress fluorogenic probe (original
magnification 40ˆ) and (B) fluorescence quantification with ImageJ software. Cell viability assay after
24 h of culture in cobalt chloride-induced hypoxic conditions (C). Treatment with the antioxidant
scavenger N-acetylcysteine (NaC) (2 mM) was used as control. Results are reported as mean ˘ S.E.M.
of three independent experiments. Significance was assessed by Mann–Whitney U test; * p < 0.05
versus ASC mock.
ccordingly, to validate our experimental design before studies involving animals, we wanted to
test the performance of mock- and SOD2-transduced, luciferase expressing murine ASCs cultured in
hypoxic co dition in vitro. T mimic the hypoxic environment which cell face upon transplantation,
we cultured luciferase-expressing ASCs in a modular airtight humidified c amber flushed with a
gas mixture which consist d of 95% N2 an 5% CO2 for three days. Bioluminescent imaging (BLI)
analysis was performed before hypoxia induction and after three days of culture in hypoxic condition
(Figure 3). At the 72 h time point, BLI imaging signal detected in SOD2-overexpressing c lls was
statistically significantly higher than the one observed in mock t ansduced cells (Figure 3B). In the
current experimental setting, stronger bioluminescence signal correlates with improv d survival of
SOD2-expressing cells, compared to mock (GFP)-transduced control. BLI analysis performed on cells
undergoing the s me gene transfer procedure, but mai tained in normoxic co dition did not reveal
any significant difference amongst the gr ups.
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of three different independent experiments performed in duplicate. The asterisk indicates a 
significant difference determined by unpaired Mann–Whitney U test (p < 0.05); (B) A representative 
BLI analysis and quantification of ASCs cultured in hypoxic condition for three days. 
2.3. ASCs Expressing SOD2 Have an Improved Engraftment Rate into a Matrigel Plug in Vivo 
Luciferase expressing ASCs were transduced with LV vectors expressing either GFP as control 
or SOD2, as described above. Then cells were mixed with Cultrex and a plug containing 7 × 105 cells 
was administered subcutaneously into syngeneic mice. We followed engraftment of ASCs by BLI 
performed at different time points after gel plug implant (Figure 4). The intensity of bioluminescence 
in the group of animals receiving SOD2-expressing ASCs was consistently higher than in the group 
receiving mock transduced cells, suggesting a role of SOD2 in promoting ASCs engraftment. At 
three days after implantation, selected animals were sacrificed, gel plugs were excised and BLI 
imaging performed (Figure 5). Quantification of the bioluminescence signal from excised gel plugs 
confirmed improved engraftment of cells expressing SOD2, compared to mock transduced cells 
(Figure 5). 
 
Figure 4. SOD2-expressing ASCs show improved engraftment potential in vivo. Adipose 
tissue-derived stromal and vascular cells (ASCs) expressing luciferase after lentiviral-mediated gene 
transfer of either GFP (mock) or superoxide dismutase (SOD2) cells were injected subcutaneously  
(7 × 105 cells/mouse) into a Matrigel plug into syngeneic mice (n = 6 per group). At different time 
points, bioluminescence imaging analysis (BLI) was performed and quantified. Data are expressed  
as the ratio of the BLI signal of the SOD2 group vs. mock control group. Difference of BLI signals 
between control (GFP) and SOD2 group was significant at all analyzed time points. 
Figure 3. Luciferase positive SOD2-expressing AS s is lay improved ability to withstand hypoxia
in vitro. Murine ASCs expressing luciferas re transduced with LV vectors expr ssing either GFP as
mock control r 2 and cultured in hypoxic conditions. (A) BLI analysis was performed at thre
days of culture and intensity of bioluminescence was determined. Data are expressed as the ratio of
the BLI signal of the SOD2 group vs. mock control group. Data are expressed as mean ˘ SEM of
three different independent experiments performed in duplicate. The asterisk indicates a significant
difference determined by unpaired Mann–Whitney U test (p < 0.05); (B) A representative BLI analysis
and quantification of ASCs cultured in hypoxic condition for three days.
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Figure 4. SOD2-expressing ASCs show improved engraftment potential in vivo. Adipose
tissue-deriv stromal and vascular cell (ASCs) expressing luciferase after lentiviral-mediated gene
transfer of either GFP (mock) or superoxide dismutase (SOD2) cells were injected subcutaneously
(7 ˆ 105 cells/mouse) into a Matrigel plug into syngeneic mice (n = 6 per group). At different time
points, bioluminescence imaging analysis (BLI) was performed and quantified. Data are expressed as
the ratio of the BLI signal of the SOD2 group vs. mock control group. Difference of BLI signals between
control (GFP) and SOD2 group was significant at all analyzed time points.
2.3. ASCs Expressing SOD2 Have an Improved Engraftment Rate into a Matrigel Plug in Vivo
Luciferase expressing ASCs were transduced with LV vectors expressing either GFP as control or
SOD2, as described above. Then cells were mixed with Cultrex and a plug containing 7 ˆ 105 cells
was administered subcutaneously into syngeneic mice. We followed engraftment of ASCs by BLI
performed at different time points after gel plug implant (Figure 4). The intensity of bioluminescence
in the group of animals receiving SOD2-expressing ASCs was consistently higher than in the group
receiving mock transduced cells, suggesting a role of SOD2 in promoting ASCs engraftment. At three
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days after implantation, selected animals were sacrificed, gel plugs were excised and BLI imaging
performed (Figure 5). Quantification of the bioluminescence signal from excised gel plugs confirmed
improved engraftment of cells expressing SOD2, compared to mock transduced cells (Figure 5).Int. J. Mol. Sci. 2016, 17, 1082 6 of 12 
 
 
Figure 5. SOD2-expressing ASCs show improved engraftment potential: ex vivo gel plug BLI 
analysis. Analysis of gel plugs excised at necropsy from one representative animal per group three 
days after implantation of Cultrex containing 7 × 105 luciferase-positive ASCs expressing either GFP 
(mock control) or SOD2. Quantification of the BLI signals in the respective selected regions of interest 
(indicated by the red lines) confirmed improved engraftment of SOD2-expressing cells compared to 
mock control. Scale bar: 1 cm. 
3. Discussion 
Finding new avenues to promote cell survival of transplanted cells would represent an 
important strategic advancement to the clinical success of cell therapy for regenerative medicine. 
Upon administration, transplanted cells encounter severe conditions, characterized by poor blood 
supply, low nutrients and excess of oxygen species (ROS), which initiate a cascade of events that 
leads to apoptotic cell death, preventing cell survival in the early stages after transplant [31]. 
Therefore, early survival of transplanted cells ultimately dictates their possibility of engraftment 
and, in the end, their therapeutic potential. In fact, even if it is not possible to rule out a possible 
beneficial effect triggered by nonviable cells [32], persistence of transplanted cells is critical for the 
success of cell-based therapies for tissue regeneration. 
Oxidative stress is characterized by an imbalance between the pro-oxidant and anti-oxidant 
stimuli leading to lipid peroxidation and protein and DNA damages. To cope with increased ROS 
levels, cells up-regulate the expression of antioxidant enzymes such as superoxide dismutase and 
catalase, which limit the levels of superoxide and hydrogen peroxide, respectively. In particular, 
modulation of SOD2 has been observed in adipose tissue of obese patients, possibly to mitigate 
mitochondrial dysfunction correlated with the pathophysiology of obesity [33]. Accordingly, 
transplantation of genetically modified SOD2-overexpressing mesenchymal cells has been 
suggested as a new therapeutic approach for obesity-associated metabolic syndrome [34]. Moreover, 
SOD2 has been identified as one of the genes mediating the late phase of ischemic preconditioning, 
defined as an increased tolerance to ischemia and reperfusion induced by a previous sub-lethal 
period of ischemia [35]. Hypoxic preconditioning of stem cells has been associated with improved 
regenerative abilities and enhanced in vivo homing to the site of injury [5,12,36]. Moderate hypoxic 
preconditioning has also been associated with an increase of ASCs proangiogenic properties [37]. 
The cytoprotective effects of preconditioning can also be achieved by pharmacological treatment, 
heat shock intervention and gene transfer to promote expression of pro survival genes [11]. 
Unfortunately, development of SODs as pharmaceutical products has been hampered by 
unfavorable pharmacologic and pharmacokinetic properties of the enzymes [38,39]. To counteract 
SOD rapid renal clearance, gene therapy approaches have been proposed to achieve robust SOD 
expression and enhanced recovery of tissue injuries has been described [40]. 
We investigated the possibility of improving survival of transplanted cells against excessive 
ROS production by SOD2 ex vivo gene transfer. Hypoxia, due to poor vascularization, and anoikis, 
triggered by the lack of connection of cells with the extracellular matrix, are considered the main 
mechanisms responsible for reduced survival of transplanted cells. Both hypoxic stress and ECM 
detachment promotes ROS excess. SOD actively dismutates superoxide anions to hydrogen 
peroxide and molecular oxygen, thus neutralizing the oxygen radicals. Consequently, SOD 
overexpression is instrumental both to protect cells from oxidative stress and anoikis [19]. 
Figure 5. SOD2-expressing ASCs show improved engraftment potential: ex vivo gel plug BLI analysis.
Analysis of gel plugs excised at necropsy from one representative animal per group three days after
implantation of Cultrex containing 7 ˆ 105 luciferase-positive ASCs expressing either GFP (mock
control) or SOD2. Quantification of the BLI signals in the respective selected regions of interest
(indicated by the red lines) confir ed i proved engraft ent of SOD2-expressing cells co pared to
ock control. Scale bar: 1 c .
3. Discussion
Finding new avenues to promote cell survival of transplanted cells would represent an important
strategic advancement to the clinical success of cell therapy for regenerative medicine. Upon
administration, transplanted cells encounter severe conditions, characterized by poor blood supply,
low nutrients and excess of oxygen species (ROS), which initiate a cascade of events that leads to
apoptotic cell death, preventing cell survival in the early stages after transplant [31]. Therefore, early
survival of transplanted cells ultimately dictates their possibility of engraftment and, in the end, their
therapeutic potential. In fact, even if it is not possible to rule out a possible beneficial effect triggered
by nonviable cells [32], persistence of transplanted cells is critical for the success of cell-based therapies
for tissue regeneration.
Oxidative stress is characterized by an imbalance between the pro-oxidant and anti-oxidant stimuli
leading to lipid peroxidation and protein and DNA damages. To cope with increased ROS levels, cells
up-regulate the expression of antioxidant enzymes such as superoxide dismutase and catalase, which
limit the levels of superoxide and hydrogen peroxide, respectively. In particular, modulation of SOD2
has been observed in adipose tissue of obese patients, possibly to mitigate mitochondrial dysfunction
correlated with the pathophysiology of obesity [33]. Accordingly, transplantation of genetically
modified SOD2-overexpressing mesenchymal cells has been suggested as a new therapeutic approach
for obesity-associated metabolic syndrome [34]. Moreover, SOD2 has been identified as one of the genes
mediating the late phase of ischemic preconditioning, defined as an increased tolerance to ischemia and
reperfusion induced by a previous sub-lethal period of ischemia [35]. Hypoxic preconditioning of stem
cells has been associated with improved regenerative abilities and enhanced in vivo homing to the
site of injury [5,12,36]. Moderate hypoxic preconditioning has also been associated with an increase of
ASCs proangiogenic properties [37]. The cytoprotective effects of preconditioning can also be achieved
by pharmacological treatment, heat shock intervention and gene transfer to promote expression of
pro survival genes [11]. Unfortunately, development of SODs as pharmaceutical products has been
hampered by unfavorable pharmacologic and pharmacokinetic properties of the enzymes [38,39]. To
counteract SOD rapid renal clearance, gene therapy approaches have been proposed to achieve robust
SOD expression and enhanced recovery of tissue injuries has been described [40].
We investigated the possibility of improving survival of transplanted cells against excessive
ROS production by SOD2 ex vivo gene transfer. Hypoxia, due to poor vascularization, and anoikis,
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triggered by the lack of connection of cells with the extracellular matrix, are considered the main
mechanisms responsible for reduced survival of transplanted cells. Both hypoxic stress and ECM
detachment promotes ROS excess. SOD actively dismutates superoxide anions to hydrogen peroxide
and molecular oxygen, thus neutralizing the oxygen radicals. Consequently, SOD overexpression is
instrumental both to protect cells from oxidative stress and anoikis [19].
For precisely determining cells’ engraftment, persistence, and biodistribution after in vivo
administration, we took advantage of the sensitive in vivo bioluminescence imaging technique (BLI).
The procedure is non-invasive and facilitates repetitive imaging, thereby providing unprecedented
insight to monitor on the same animal over time transplanted cell survival, proliferation and migration.
Limitations of the procedure are associated to the fact that to produce a bioluminescence signal,
which can be detected, transplanted luciferase-expressing cells should uptake and convert luciferin.
Poor blood supply in the area of cell implantation may limit diffusion of luciferase administered by
intraperitoneal administration. Conversely, during time, the formation of a vascular network into the
Matrigel plug by ASCs may facilitate exposure of transplanted cells to luciferase, therefore leading
to an increment of BLI signal. Another factor that should be taken into account in our experimental
design is that the light-producing enzymatic conversion of luciferin to oxyluciferin requires ATP and
oxygen [41]. Therefore, only living cells expressing luciferase will be able to produce a BLI signal; in
other words, BLI intensity correlates with the number cells surviving the transplantation procedure.
On the other hand, in the absence of an adequate oxygen supply, luciferase-expressing cells may not
be able to fully convert luciferin, leading to an underestimation of the number of engrafted cells in a
hypoxic environment.
In summary, we describe a gene therapy approach aimed at increasing the regenerative efficacy of
cell therapy by conferring to the transplanted cells improved oxidative stress resistance. Notably, these
results are in accordance with previous reports associating viral mediated overexpression of SOD with
improved survival of transplanted pancreatic islet [42] and wound healing mediated be endothelial
progenitor cells administration [43].
4. Experimental Section
4.1. Experimental Animals
We used adult FVB wild-type mice from colonies maintained in our institutional animal
facility. All experimental procedures conformed to protocols approved by the Regina Elena National
Cancer Institute Animal Care and Use Committee, and by the General Directorate for Animal
Health and Veterinary Medicinal Products of the Italian Ministry of Health (Authorization n˝
1001/2015-PR, 22 September 2015), according to the current National Legislation (Art. 31 D.lgs
26/2014, 4 March 2014).
4.2. Cells Isolation and Culture
Human ASC were isolated from lipoaspirates collected from the thigh and hip regions of 6 healthy,
non obese (Body Mass Index below 30 kg/m2), Caucasian females (age range 25–56 years) undergoing
liposuction, as previously described [24]. All donors gave their written informed consent in accordance
with the standards of the University of Rome “La Sapienza” Ethical Committee (Authorization
n˝ 1794/15, 13 February 2015) and the principles expressed in the Declaration of Helsinki. Murine
adipose tissue-derived stromal cells (ASCs) [23] were isolated from 6–8 week-old FVB mice as
previously described [44]. Briefly, inguinal subcutaneous fat pads were digested for 45 min in a
shaking water bath at 37 ˝C in phosphate buffered saline (PBS) containing 2% bovine serum albumin
(BSA) and 2 mg/mL collagenase A (Roche Diagnostics, Mannheim, Germany). Tissue debris were
eliminated by filtration through a 40 µm cell strainer (BD Falcon, Franklin Lakes, NJ, USA) and cells
collected by centrifugation (500ˆ g). Cells were then washed in PBS, counted and used either for gene
transfer procedures or culture. For cell culture cells were plated at 2.5 ˆ 104 cells/cm2 in α-MEM
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supplemented with 20% FBS, 2 mM L-glutamine, 1% penicillin-streptomycin in incubator at 37 ˝C
and 5% CO2. The next day non-adherent cells were discarded, medium replaced and adipose-derived
adherent stromal cells were allowed to grow until they reached 80% confluence.
We used different methods for induction of hypoxia in cell culture [45]. In some experiments,
hypoxia was induced by placing cell culture dishes in airtight modular incubator chambers (Forma
Scientific, Mountain View, CA, USA), flushed for 20 min with 95% N2 plus 5% CO2. In these
conditions, oxygen concentration is approximately 1% [46]. Chambers were then sealed and placed in
an incubator at 37 ˝C for the duration of the experiments. Alternatively, ASCs were incubated for 24 h
in culture medium supplemented with CoCl2 (Sigma-Aldrich, St. Louis, MO, USA). Oxidative stress
induction was also achieved by adding 1 mM H2O2 to ASC culture medium for 30 min. The CellROX
Oxidative Stress Reagents fluorogenic probe (Thermo Fisher Scientific, Waltham, MA, USA) was used
to measure reactive oxygen species (ROS) in live cells according to manufacturer’s specifications. This
cell-permeable dye is weakly fluorescent in reduced state while in the presence of ROS it is converted
to the oxidized form which emits a fluorescence signal directly proportional to oxidation and thus to
the amount of ROS. Quantification of green fluorescence was performed using the ImageJ software
(National Institutes of Health, Bethesda, MD, USA), as previously described [16]. Cell proliferation
was measured using the WST-1 cell proliferation assay kit (Takara, Clontech, Mountain View, CA,
USA), according to manufacturer’s instructions.
4.3. Lentiviral Vectors Production
We generated a third-generation self-inactivating lentiviral vector (LV) expressing human SOD2
by cloning the full-length cDNA for SOD2 derived from pcDNA3SOD2 [47], as replacements to the
E-GFP cDNA into the pCCLsin.cPPT.hPGK.E-GFP.Wpre (phosphoglycerate kinase promoter–enhanced
jellyfish green fluorescent protein) plasmid [30], generously provided by Elisa Vigna (IRCC, Candiolo,
Italy). Generation of a lentiviral vector expressing firefly luciferase has been previously described [48].
Recombinant vesicular stomatitis virus–pseudotyped LVs were obtained according to published
protocols [49]. Titer of GFP-expressing LV stocks used as control was determined by serial dilution on
HeLa cells and flow cytometry analysis and was above 1 ˆ 108 transducing units/mL (TU/mL).
4.4. Lentiviral-Mediated Gene Transfer into ASCs
Freshly isolated ASCs were transduced with a procedure named SLIT for “Suspension with
Lentiviral vectors and Immediately Transplanted”, originally described for efficient lentiviral-mediated
gene transfer into primary hepatocytes [28]. Briefly, uncultured ASCs were resuspended at a cell
density of 5 ˆ 105 cells/mL in saline solution and exposed to lentiviral vectors at a multiplicity of
infection of 30 for 2 h, with occasional shaking. Cells were then carefully washed and cultured as
described above.
4.5. Immunoblotting and Activity Analysis
Expression of human SOD2 after lentiviral-mediated gene transfer was assessed by Western blot
analysis using primary antibodies against SOD2 (1:1000) (Upstate Biotechnology–Millipore, Temecula,
CA, USA), according to established protocols [50]. Densitometry analysis was performed using
the ImageJ software (National Institutes of Health, Bethesda, MD, USA) to normalize the signals
against glyceraldehyde phosphate dehydrogenase (GAPDH), considered as a loading control. SOD
activity was assayed by non-denaturing polyacrylamide gel electrophoresis and staining with nitro
blue tetrazolium, as previously described [50]. SOD activity was further assessed using the SOD
determination kit (Sigma-Aldrich, St. Louis, MO, USA) according to the manufacturer’s instructions.
4.6. In Vivo Gel Plug Assay
The assay is based on the implant of Matrigel® plugs and was performed as previously
described [24]. Briefly, ASCs were resuspended in PBS and mixed with Cultrex® growth factor
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reduced basement membrane extract (Trevigen Inc., Gaithersburgh, MD, USA). An aliquot of 400 µL
of Cultrex® containing 7 ˆ 105 cells was therefore injected subcutaneously into syngeneic mice.
4.7. Ex Vivo and in Vivo Optical Bioluminescent Imaging
Bioluminescent imaging (BLI) analysis was performed using the IVIS® Lumina II equipped
with the Living Image® software for data quantification (PerkinElmer, Waltham, MA, USA). For
ex vivo imaging, ASCs and gel plug explants containing luciferase expressing cells were placed
into clear bottom tissue culture dishes and incubated in a saline solution containing D-luciferin
(PerkinElmer) (150 µg/mL) before analysis. For in vivo analysis, mice were anesthetized with Avertin®
(2,2,2-tribromoethanol; Sigma-Aldrich, St. Louis, MO, USA) (240 mg/kg) and D-luciferin dissolved
in PBS (150 mg/kg body weight) was administered i.p. 10 min before analysis [48]. Photons emitted
from luciferase-expressing ASCs transplanted into the animals were collected with final accumulation
times of 1 to 5 min, depending on the intensity of the bioluminescence emission.
4.8. Statistical Analysis
Results are expressed as means ˘ standard error of the mean (SEM). Data analysis and
comparisons between control and treated groups were performed and the significance of differences
was assessed with Mann–Whitney U test for unpaired data; statistical significance level was set
at p ď 0.05.
5. Conclusion
Ex vivo gene transfer of human manganese superoxide dismutase into adipose tissue-derived
stromal cells before implantation confers a cytoprotective effect leading to improved survival to
hypoxia in vitro and increased engraftment rates in vivo. Therefore, cell preconditioning mediated by
SOD2 gene transfer might constitute a suitable method to increase the efficacy of cell-based therapies
to promote tissue regeneration.
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